More Automotive Antics

News drove several auto stocks today, so let’s review. 👇

First, let’s start with GM-owned Cruise, which is experiencing a lot of trouble in the autonomous driving market. The California Department of Motor Vehicles (DMV) recently suspended its driverless permits over several issues. That caused the company to suspend all driverless taxi operations and pause production of its vehicles. 🛑

Additionally, reporters continue investigating the company’s safety record and “self-driving” claims. The Intercept reported that Cruise kept its vehicles on the roads despite knowing they had problems recognizing children. It also referenced that robotaxis aren’t really fully autonomous, given they require human assistance every four to five miles.

That claim references Hacker News, which targeted the company’s self-driving claims, noting that Cruise vehicles allegedly rely on human operators to achieve. In response, Cruise’s CEO wrote, “Cruise AVs are being remotely assisted (RA) 2%-4% of the time on average, in complex urban environments. This is low enough already that there isn’t a huge cost benefit to optimizing much further, especially given how useful it is to have humans review things in certain situations.” 🤔

Overall, autonomous vehicles are facing several regulatory and trust issues. Although massive investments have been made in the space, it appears that the mass adoption of fully autonomous driving is still a long way off. $GM shares remain under pressure due to this, along with broader issues in the automobile market (like electric vehicle pricing and labor costs). 

Next, Stellantis’ 2025 Ram Ramcharger is an electric truck that gets its power from a gas-powered generator. The company wants this new vehicle to be viewed as a “battery electric truck,” having a 92-kilowatt-hour battery pack with 145 miles of range. It also has a 3.6-liter V6 engine onboard a 130-kilowatt generator, which gives the truck a targeted range of 690 miles. Given the recent hiccups in the pure electric vehicle market, automakers are getting more creative in the offerings they develop and market to U.S. consumers. 🔋

Moving onto earnings, Rivian is up marginally after the bell. The electric adventure vehicle manufacturer posted a narrower-than-expected quarterly loss of $1.19 per share on $1.34 billion in revenues. Analysts had expected a loss of $1.34 per share on $1.32 billion in revenues. 🔺

The company delivered 15,564 vehicles during its last quarter, with minimal regulatory credit sales impacting revenue. It continues to ramp up production, raising its production guidance for the current year from 52,000 to 54,000 vehicles. It’s also reduced its full-year capital expenditures forecast to $1.1 billion as it looks to preserve cash following a $1.5 billion convertible debt offering last month. Lastly, its exclusivity agreement with Amazon will end earlier than anticipated, allowing the company to diversify its customer base. 

On the other hand, luxury electric vehicle maker Lucid is falling 5% after cutting its full-year production outlook. It now expects to produce 8,000 to 8,500 cars, down from its previous forecast of 10,000 (and 12,000 to start the year). That said, its third-quarter loss per share of $0.28 was $0.12 better than expected. However, its sales of $138 million lagged estimates of $178 million as it continues to struggle with slowing EV demand. 🔻

With production slowing to align more adequately with expected demand, investors want to see its cash management improve. The company used $707 million during the quarter, better than last quarter’s $900 million and the $890 million anticipated by analysts. With the high-end EV market expected to remain challenging, the stock is falling back toward its all-time lows set last month. 📉

Justice Department Targets UnitedHealth

With the upcoming presidential election looming, the current administration is itching to accomplish more before a potential shakeup. While antitrust regulators have had a field day with big tech, airlines, grocery chains, and others this year, they’re taking another look at UnitedHealth, especially given its recent cybersecurity issues. 🕵️‍♂️

The Justice Department is poking around to figure out the relationship between the company’s UnitedHealthcare insurance unit and its Optum health-services division. They’ve asked how UnitedHealth’s acquisitions of doctor groups might affect competitors and consumers. 🤔

Read It

Biotech Buyout Spree Continues

It may be the last week of the year, but many companies are rushing to get deals done before year-end. Two significant transactions in the biotech space were announced today, so let’s dive in. 👇

The first deal involves RayzeBio, which raised $358 million via an initial public offering (IPO) just three months ago. However, its time as a public company is being cut short by Bristol Myers Squibb, which is acquiring the radiopharmaceutical therapeutics company for $62.50 per share in cash. 💰

Read It

FanDuel Parent Lists On NYSE

The U.S. “degenerate economy” is getting its latest entrant, with FanDuel parent company Flutter Entertainment making its debut on the New York Stock Exchange (NYSE) today. 🤩

With that said, the company did not receive the traditional fanfare it would in a standard initial public offering (IPO). That’s because it was listed on the London Stock Exchange (LSE) in May 2019, and its American depository receipts (ADR) have traded over the counter under the ticker $PDYPY for years.

Read It

PayPal Pops Ahead Of Key Event

It’s been a rough few years for payment giant PayPal, with shares falling 85% peak-to-trough. Recently, the stock has begun to rebound with other beaten-down tech names but remains about 80% below all-time highs. In other words, it would need to nearly 5x its share price to reach those levels again. 📈

While that may seem a ways off, investors have recently pushed shares to their best three-day run since the end of 2022. That’s because the company promised to roll out new “customer-backed innovation” at an event next Thursday, with its new CEO Alex Chriss saying, “It is very clear what we need to do.”

Read It